Nicastrin Palmitoylation and Biology of Gamma Secretase
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004104
Summary
Recent research efforts have uncovered a common thread that connects the effects of mutations in the proteins termed Presenilin 1, Presenilin 2 and the amyloid precursor protein (APP). All three mutant proteins increase the production of toxic beta-amyloid peptide (Aß), which accumulates in the brains of individuals with Alzheimer’s disease (AD). Dr. Thinakaran’s research seeks to gain new information regarding the molecules that play an essential role in the production of Aß peptides. Presenilins and a few other proteins act together to generate Aß by the enzymatic cleavage of amyloid precursor protein. Recently, specialized microdomains in the cell surface, called lipid raft, were found to be involved in the production of Aß. A better understanding of the relationship between Presenilin and associated proteins and lipid rafts will shed more light on the mechanisms involved in Aß production, and perhaps, lead to new therapeutic interventions for Alzheimer’s disease (AD).
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD